×
About 16,818 results

ALLMedicine™ Menopause Center

Research & Reviews  5,146 results

Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP.
https://doi.org/10.1038/s41582-021-00544-2 10.1016/S0140-6736(16)31678-6 10.1016/S1474-4422(16)30293-9 10.1212/01.wnl.0000252808.97649.21 10.1111/head.13342 10.3389/fnins.2020.00222 10.1177/0333102414559735 10.1186/s10194-018-0846-2 10.1016/S1474-4422(18)30322-3 10.1186/s10194-020-01208-0 10.1038/s41582-018-0003-1 10.1007/s40263-019-00630-6 10.1111/head.12978 10.1016/j.nbd.2014.03.008 10.1016/j.mayocp.2017.11.027 10.1016/j.pharmthera.2006.08.009 10.1186/s10194-018-0853-3 10.1212/01.WNL.0000133134.68143.2E 10.1186/1129-2377-16-S1-A24 10.1016/j.maturitas.2020.07.005 10.1186/s10194-018-0922-7 10.1016/S0140-6736(00)84315-9 10.1016/S1474-4422(20)30482-8 10.1111/j.1526-4610.2008.01310.x 10.1212/WNL.22.4.355 10.1016/S1474-4422(04)00768-9 10.1002/phar.1876 10.1177/2053369117731172 10.1186/s10194-020-01150-1 10.1097/GME.0000000000001104 10.1111/j.1526-4610.2011.01908.x 10.1111/j.1526-4610.1972.hed1203093.x 10.1186/1744-8069-8-16 10.1177/0333102417710636 10.1097/j.pain.0000000000001561 10.1016/j.jsbmb.2014.09.001 10.1177/0333102417739584 10.3389/fnint.2020.00026 10.3389/fnins.2020.00796 10.1177/0333102420937742 10.1016/j.steroids.2016.04.005 10.1046/j.1526-4610.1996.3610579.x 10.1111/j.1460-9568.2006.04602.x 10.1016/j.pneurobio.2010.04.009 10.1111/head.13082 10.1210/jcem-52-5-988 10.1046/j.1365-2826.1997.00654.x 10.1530/JOE-11-0358 10.1262/jrd.2012-139 10.1073/pnas.86.7.2468 10.1113/jphysiol.1906.sp001148 10.1016/S0021-9258(18)49238-1 10.1186/s12884-019-2365-9 10.1007/s00441-018-2960-5 10.1016/j.neuron.2016.01.041 10.1152/physrev.00031.2017 10.1124/pr.120.019398 10.1007/7854_2017_14 10.1515/jpme.1985.13.1.3 10.1292/jvms.65.707 10.1210/jcem-53-6-1229 10.1016/j.yfrne.2018.11.002 10.1177/0333102420929027 10.1177/0333102415618615 10.1016/j.neuropharm.2017.11.031 10.1186/s10194-020-1079-8 10.1016/j.brainres.2019.02.002 10.1038/s41598-018-31361-1 10.1016/j.pain.2013.05.003 10.1002/cne.24282 10.1111/j.1365-2265.1976.tb03867.x 10.1016/j.tins.2020.06.003 10.1002/ana.26070 10.1530/eje.0.1500737 10.1007/s13311-017-0602-3 10.1111/j.1526-4610.2007.00842.x 10.1186/s10194-020-01134-1 10.1177/0333102418786261 10.1111/head.13300 10.1146/annurev-physiol-030212-183717 10.1177/0333102411398152 10.1016/j.brainres.2008.02.078 10.1111/j.1468-2982.2008.01829.x 10.1016/j.pain.2013.07.021 10.1007/s10072-017-2866-0 10.1177/0333102419867280 10.1097/WCO.0000000000000441 10.1097/PR9.0000000000000745 10.1523/JNEUROSCI.1088-18.2018 10.3389/fneur.2020.00140 10.1212/WNL.0000000000007607 10.1097/j.pain.0000000000001531 10.3389/fneur.2019.00961 10.1186/s12880-018-0272-6 10.1111/head.13529 10.1016/j.brainres.2014.11.031 10.1016/S0140-6736(19)32504-8 10.1186/s10194-020-01167-6 10.3390/brainsci11030370 10.1177/0333102415584308 10.1177/0333102417728873 10.1210/er.2018-00087 10.1146/annurev-med-050913-021703 10.1016/j.jsbmb.2015.06.014 10.1016/j.archoralbio.2005.03.010 10.1186/s10194-020-01197-0 10.1111/jne.12402 10.1002/jnr.21980 10.1073/pnas.0705936104 10.1016/j.ejpain.2009.05.008 10.1016/j.yfrne.2013.06.001 10.1111/j.1526-4610.2012.02249.x 10.1002/cne.20569 10.3389/fendo.2020.00537 10.1016/S0169-328X(02)00525-9 10.18632/oncotarget.23141 10.3389/fneur.2020.549038 10.1111/j.1526-4610.2006.00309.x 10.1007/s10072-020-04643-8 10.3390/ijms20225729 10.3389/fmolb.2018.00073 10.1371/journal.pone.0178589 10.1007/BF03405853 10.1016/j.expneurol.2014.09.011 10.1002/jcp.22671 10.1111/j.1468-2982.2005.00987.x 10.1016/j.npep.2005.04.002 10.1038/s41598-020-72285-z 10.1111/j.1526-4610.2006.00685.x 10.1016/j.neuint.2016.12.021 10.1210/en.2012-2253 10.1002/cne.20127 10.1016/j.physbeh.2016.05.047 10.1016/j.brainres.2006.01.050 10.1016/j.expneurol.2019.113079 10.1016/0006-8993(89)90317-X 10.1016/j.psyneuen.2014.03.023 10.1016/j.neulet.2009.02.062 10.1016/j.npep.2012.09.008 10.1097/j.pain.0000000000000808 10.1124/mol.118.114744 10.1016/j.neuroscience.2014.12.058 10.1213/ANE.0b013e31823b1bc8 10.1016/0006-8993(87)91337-0 10.1016/0304-3940(85)90316-7 10.1016/j.neuroscience.2010.05.016 10.1111/j.1526-4610.2011.01882.x 10.1186/s10194-019-1055-3 10.1007/s00429-019-02019-z 10.1016/j.neuroimage.2013.12.016 10.1080/14656566.2017.1414182 10.1007/s11910-020-01067-x 10.1007/s10194-012-0455-4 10.1111/j.1468-2982.2009.01840.x 10.1177/0333102410378049 10.1111/head.13291 10.1046/j.1468-2982.1999.019002124.x 10.1001/jama.2017.16952 10.1016/S1550-8579(05)80059-2 10.1016/S0140-6736(19)31709-X 10.1158/0008-5472.CAN-13-3400 10.1111/j.1526-4610.2009.01594.x 10.1038/nrneurol.2016.93
Nature Reviews. Neurology; Krause DN, Warfvinge K et. al.

Sep 22nd, 2021 - Migraine is ranked as the second highest cause of disability worldwide and the first among women aged 15-49 years. Overall, the incidence of migraine is threefold higher among women than men, though the frequency and severity of attacks varies dur...

Hand grip strength and health-related quality of life in postmenopausal women: a nation...
https://doi.org/10.1097/GME.0000000000001863
Menopause (New York, N.Y.); Hong YS, Kim H

Sep 22nd, 2021 - Muscle strength progressively decreases after menopause. Hand grip strength (HGS) reflects overall muscle strength and may be associated with health-related quality of life (HRQoL). We aimed to assess the association between HGS and HRQoL in postm...

Cognitive health after menopause: Does menopausal hormone therapy affect it?
https://doi.org/10.1016/j.beem.2021.101565
Best Practice & Research. Clinical Endocrinology & Metabo... Petra S, Johanna W et. al.

Sep 21st, 2021 - Dementia is a pandemic chronic non-communicable disease. 10 in 100 women above age 65 will be diagnosed with dementia, primarily Alzheimer's disease (AD). Apart from age and hereditary risk factors, there are multiple acquired risk and protective ...

The effects of mindfulness stress reduction program on postmenopausal women's menopausa...
https://doi.org/10.1016/j.ctcp.2021.101478
Complementary Therapies in Clinical Practice; Şener N, Timur Taşhan S

Sep 21st, 2021 - This study was carried out to define the effect of the Mindfulness Stress Reduction Program (MBSR) applied among postmenopausal women on their menopausal complaints and quality of life. The study was conducted with a quasi-experimental design. The...

Associations of age at menopause with postmenopausal bone mineral density and fracture ...
https://doi.org/10.1210/clinem/dgab690
The Journal of Clinical Endocrinology and Metabolism; Shieh A, Ruppert KM et. al.

Sep 20th, 2021 - Menopause before age 45 is a risk factor for fractures, but menopause occurs at age 45 or later in ~90% of women. To determine, in women with menopause at age 45 or later, whether: 1) years since the FMP is more strongly associated with postmenopa...

see more →

Guidelines  41 results

Guideline No. 422d: Menopause and Sexuality.
https://doi.org/10.1016/j.jogc.2021.09.005
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Wolfman W, Krakowsky Y et. al.

Sep 20th, 2021 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...

Guideline No. 422b: Menopause and Genitourinary Health.
https://doi.org/10.1016/j.jogc.2021.09.001
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Johnston S, Bouchard C et. al.

Sep 11th, 2021 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...

Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Com...
https://doi.org/10.1016/j.jogc.2021.08.003
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Yuksel N, Evaniuk D et. al.

Aug 15th, 2021 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...

Guideline No. 404: Initial Investigation and Management of Benign Ovarian Masses.
https://doi.org/10.1016/j.jogc.2020.01.014
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Wolfman W, Thurston J et. al.

Aug 2nd, 2020 - To provide recommendations for a systematic approach to the initial investigation and management of a benign ovarian mass and facilitate patient referral to a gynaecologic oncologist for management. Obstetricians, gynaecologists, family physicians...

Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin, Number 224.
https://doi.org/10.1097/AOG.0000000000003944
Obstetrics and Gynecology;

Jun 27th, 2020 - Vulvar skin disorders include a variety of inflammatory conditions of the vulva that also may affect the extragenital area. Pruritus and pain are two of the most common presenting symptoms in vulvar clinics (). Vulvovaginal symptoms often are chro...

see more →

Drugs  236 results see all →

News  1,286 results

2018 AHA/ACC Multisociety Cholesterol Guideline vs 2019 ESC/EAS Dyslipidemia Guidelines: 5 Things to Know
https://www.medscape.com/viewarticle/952765

Jun 30th, 2021 - The 2018 American Heart Association (AHA)/American College of Cardiology (ACC) Multisociety Cholesterol Guideline and the 2019 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) Guidelines for the Management of Dyslipidaem...

Prisoners Going Through Menopause Get 'Double Punishment'
https://www.medscape.com/viewarticle/953544

Jun 23rd, 2021 - (Reuters Health) - For a growing population of aging incarcerated women, the transition to menopause can be especially fraught yet largely overlooked by prison healthcare systems, a new review shows. "Folks who are incarcerated are more likely to ...

Primary Ovarian Insufficiency Requires Long-term Management of Sequelae
https://www.medscape.com/viewarticle/951400

May 18th, 2021 - Primary ovarian insufficiency is not your mother's early menopause, Laurie McKenzie, MD, told attendees at the 2021 annual meeting of the American College of Obstetricians and Gynecologists. Known previously as primary ovarian failure, the syndrom...

Commission Outlines Plan for Global Fight Against CVD in Women
https://www.medscape.com/viewarticle/951246

May 16th, 2021 - An expert panel convened by The Lancet calls for urgent action to reduce the global burden of cardiovascular disease (CVD) in women and has outlined an ambitious agenda to accomplish that goal. The report, from the all-female-led Lancet Women and ...

Gene Variants Tied to Reproductive Aging Also Tied to Vasomotor Menopause Symptoms
https://www.medscape.com/viewarticle/950787

May 10th, 2021 - (Reuters Health) - Certain genetic variants that are associated with reproductive aging also appear linked to vasomotor symptoms of menopause, a new study suggests. Researchers examined data from the Study of Women's Health Across the Nation (SWAN...

see more →

Patient Education  18 results see all →